Cargando…

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease

Chronic cholestatic liver diseases are characterized by injury of the bile ducts and hepatocytes caused by accumulated bile acids (BAs) and inflammation. Wnt/β‐catenin signaling is implicated in organ fibrosis; however, its role in cholestatic liver fibrosis remains unclear. Therefore, we explored t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Masamichi, Nishikawa, Koji, Osawa, Yosuke, Imamura, Jun, Yamaji, Kenzaburo, Harada, Kenichi, Yatsuhashi, Hiroshi, Murata, Kazumoto, Miura, Kouichi, Tanaka, Atsushi, Kanto, Tatsuya, Kohara, Michinori, Kamisawa, Terumi, Kimura, Kiminori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512479/ https://www.ncbi.nlm.nih.gov/pubmed/35855613 http://dx.doi.org/10.1002/hep4.2043

Ejemplares similares

Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
por: Tokunaga, Yuko, et al.
Publicado: (2017)

Feasibility, safety and tolerability of the CREB-binding protein/β-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study
por: Kimura, Masamichi, et al.
Publicado: (2022)

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
por: Kimura, Kiminori, et al.
Publicado: (2017)

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study
por: Kimura, Kiminori, et al.
Publicado: (2022)

Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
por: Osawa, Yosuke, et al.
Publicado: (2015)

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers
por: Osawa, Yosuke, et al.
Publicado: (2019)

Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs
por: Nishikawa, Koji, et al.
Publicado: (2018)

Tumor necrosis factor‐α‐mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice
por: Osawa, Yosuke, et al.
Publicado: (2018)

Rapidly Progressing Sarcomatoid Hepatocellular Carcinoma after Needle Biopsy and Radiofrequency Ablation
por: Kimura, Masamichi, et al.
Publicado: (2023)

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
por: Sanada, Takahiro, et al.
Publicado: (2023)

M2 Macrophages Play Critical Roles in Progression of Inflammatory Liver Disease in Hepatitis C Virus Transgenic Mice
por: Ohtsuki, Takahiro, et al.
Publicado: (2015)

Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C
por: Ezzikouri, Sayeh, et al.
Publicado: (2015)

Inhibition of the canonical Wnt signaling pathway by a β-catenin/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis
por: Methatham, Thanachai, et al.
Publicado: (2021)

Immunoglobulin G4-related Disease: A New Systemic Disease Emerging in Japan
por: Kamisawa, Terumi
Publicado: (2021)

The Transcriptional Coactivator Cbp Interacts with β-Catenin to Activate Gene Expression
por: Takemaru, Ken-Ichi, et al.
Publicado: (2000)

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
por: Manegold, Philipp, et al.
Publicado: (2018)

Application of spatial transcriptomics analysis using the Visium system for the mouse nasal cavity after intranasal vaccination
por: Toyama, Sakiko, et al.
Publicado: (2023)

Development and Characterization of a Highly Sensitive NanoLuciferase-Based Immunoprecipitation System for the Detection of Anti-Influenza Virus HA Antibodies
por: Honda, Tomoko, et al.
Publicado: (2021)

CBP/Catenin Antagonist Safely Eliminates Drug Resistant Leukemia Initiating Cells
por: Zhao, Yi, et al.
Publicado: (2015)

Loss of α-catenin elicits a cholestatic response and impairs liver regeneration
por: Herr, Keira Joann, et al.
Publicado: (2014)

Treatment of Autoimmune Pancreatitis with the Anecdotes of the First Report
por: Kamisawa, Terumi, et al.
Publicado: (2012)

Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease
por: Kamisawa, Terumi, et al.
Publicado: (2006)

Wnt3a/β-Catenin/CBP Activation in the Progression of Cervical Intraepithelial Neoplasia
por: Feng, Dingqing, et al.
Publicado: (2021)

Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease
por: Lemberger, Ursula J., et al.
Publicado: (2016)

Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells
por: Che, Mingtian, et al.
Publicado: (2020)

Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/Ribavirin therapy in chronic hepatitis C patients
por: Murata, Kazumoto, et al.
Publicado: (2013)

Small molecule inhibition of CBP/catenin interactions eliminates drug resistant clones in acute lymphoblastic leukemia
por: Gang, Eun Ji, et al.
Publicado: (2013)

Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications
por: Gravesen, Eva, et al.
Publicado: (2018)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2018)

Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage
por: Ono, Masaya, et al.
Publicado: (2018)

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
por: Kartha, Vinay K., et al.
Publicado: (2018)

The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner
por: Wiese, Maria, et al.
Publicado: (2017)

Inhibition of β‐catenin/CBP signalling improves airway epithelial barrier function and suppresses CCL20 release
por: Kuchibhotla, Virinchi N. S., et al.
Publicado: (2020)

CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2
por: Feng, Dingqing, et al.
Publicado: (2020)

Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver
por: Sekiguchi, Satoshi, et al.
Publicado: (2012)

Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex
por: Rao, Jianhua, et al.
Publicado: (2020)

Tupaia Belangeri as an Experimental Animal Model for Viral Infection
por: Tsukiyama-Kohara, Kyoko, et al.
Publicado: (2014)

Hepatitis C Virus: Viral Quasispecies and Genotypes
por: Tsukiyama-Kohara, Kyoko, et al.
Publicado: (2017)

Basic Study for Vaccine Development Targeting Virus Infections
por: Tsukiyama-Kohara, Kyoko, et al.
Publicado: (2021)

β-Catenin/CBP–Dependent Signaling Regulates TGF-β–Induced Epithelial to Mesenchymal Transition of Lens Epithelial Cells
por: Taiyab, Aftab, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9v3toq2j5ko2402ur7b1diursc